Lu‐Zhe Sun

8.0k citations
125 papers · 4.5k indexed · h-index 40
Topics
TGF-β signaling in diseases (37 papers)Cancer Cells and Metastasis (26 papers)Pancreatic and Hepatic Oncology Research (15 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Lu‐Zhe Sun

125 papers receiving 4.4k citations

Peers

Lu‐Zhe Sun
Comparison fields: 5 of 128
  • Molecular Biology 2.9k
  • Oncology 1.7k
  • Cancer Research 892
  • Pathology and Forensic Medicine 509
  • Pulmonary and Respiratory Medicine 487
Replace Claudio Festuccia with:
Claudio Festuccia Italy
Maréne Landström Sweden
Franca Stivala Italy
Hiroyuki Kato Japan
Paweł Surowiak Poland
Toshinari Minamoto Japan
Jeffrey E. Green United States
Akeila Bellahcène Belgium
Jonathan M. Kurie United States
Mai Nguyen United States
Lu‐Zhe Sun relative to Claudio Festuccia Italy Claudio Festuccia's profile →
Citations per field
00.5×1.6×
Claudio Festuccia · 1×
Citations per year

Countries citing papers authored by Lu‐Zhe Sun

Since Specialization
Citations

This map shows the geographic impact of Lu‐Zhe Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu‐Zhe Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu‐Zhe Sun more than expected).

Fields of papers citing papers by Lu‐Zhe Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu‐Zhe Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu‐Zhe Sun. The network helps show where Lu‐Zhe Sun may publish in the future.

Co-authorship network of co-authors of Lu‐Zhe Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Lu‐Zhe Sun. A scholar is included among the top collaborators of Lu‐Zhe Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu‐Zhe Sun. Lu‐Zhe Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 7
3 1
4 17
5 12
6 8
7 19
8 54
9 6
10 12
11 13
12 50
13 31
14 18
15 26
16 36
17 44
18 85
19 82
20 110

About Lu‐Zhe Sun

Lu‐Zhe Sun is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 125 papers that have together received 4.5k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (37 papers), Cancer Cells and Metastasis (26 papers) and Pancreatic and Hepatic Oncology Research (15 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (892 citations) and Molecular Biology (2.9k citations). Lu‐Zhe Sun has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Abhik Bandyopadhyay, Junhua Yang, Michael G. Brattain, James K. V. Willson, Long Wang, Elizabeth Zborowska, Changguo Chen, I‐Tien Yeh, L E Gentry and Yuping Tang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026